Cargando…

A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow

In hypoplastic left heart syndrome (HLHS), the mechanisms leading to left heart hypoplasia and their associated fetal abnormalities are largely unknown. Current animal models have limited utility in resolving these questions as they either do not fully reproduce the cardiac phenotype, do not survive...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Anum, DeYoung, Taylor, Cahill, Lindsay S., Yee, Yohan, Debebe, Sarah K., Botelho, Owen, Seed, Mike, Chaturvedi, Rajiv R., Sled, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592017/
https://www.ncbi.nlm.nih.gov/pubmed/34514502
http://dx.doi.org/10.1242/dmm.049077
_version_ 1784599376812834816
author Rahman, Anum
DeYoung, Taylor
Cahill, Lindsay S.
Yee, Yohan
Debebe, Sarah K.
Botelho, Owen
Seed, Mike
Chaturvedi, Rajiv R.
Sled, John G.
author_facet Rahman, Anum
DeYoung, Taylor
Cahill, Lindsay S.
Yee, Yohan
Debebe, Sarah K.
Botelho, Owen
Seed, Mike
Chaturvedi, Rajiv R.
Sled, John G.
author_sort Rahman, Anum
collection PubMed
description In hypoplastic left heart syndrome (HLHS), the mechanisms leading to left heart hypoplasia and their associated fetal abnormalities are largely unknown. Current animal models have limited utility in resolving these questions as they either do not fully reproduce the cardiac phenotype, do not survive to term and/or have very low disease penetrance. Here, we report the development of a surgically induced mouse model of HLHS that overcomes these limitations. Briefly, we microinjected the fetal left atrium of embryonic day (E)14.5 mice with an embolizing agent under high-frequency ultrasound guidance, which partially blocks blood flow into the left heart and induces hypoplasia. At term (E18.5), all positively embolized mice exhibit retrograde aortic arch flow, non-apex-forming left ventricles and hypoplastic ascending aortas. We thus report the development of the first mouse model of isolated HLHS with a fully penetrant cardiac phenotype and survival to term. Our method allows for the interrogation of previously intractable questions, such as determining the mechanisms of cardiac hypoplasia and fetal abnormalities observed in HLHS, as well as testing of mechanism-based therapies, which are urgently lacking.
format Online
Article
Text
id pubmed-8592017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-85920172021-11-16 A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow Rahman, Anum DeYoung, Taylor Cahill, Lindsay S. Yee, Yohan Debebe, Sarah K. Botelho, Owen Seed, Mike Chaturvedi, Rajiv R. Sled, John G. Dis Model Mech Resource Article In hypoplastic left heart syndrome (HLHS), the mechanisms leading to left heart hypoplasia and their associated fetal abnormalities are largely unknown. Current animal models have limited utility in resolving these questions as they either do not fully reproduce the cardiac phenotype, do not survive to term and/or have very low disease penetrance. Here, we report the development of a surgically induced mouse model of HLHS that overcomes these limitations. Briefly, we microinjected the fetal left atrium of embryonic day (E)14.5 mice with an embolizing agent under high-frequency ultrasound guidance, which partially blocks blood flow into the left heart and induces hypoplasia. At term (E18.5), all positively embolized mice exhibit retrograde aortic arch flow, non-apex-forming left ventricles and hypoplastic ascending aortas. We thus report the development of the first mouse model of isolated HLHS with a fully penetrant cardiac phenotype and survival to term. Our method allows for the interrogation of previously intractable questions, such as determining the mechanisms of cardiac hypoplasia and fetal abnormalities observed in HLHS, as well as testing of mechanism-based therapies, which are urgently lacking. The Company of Biologists Ltd 2021-11-10 /pmc/articles/PMC8592017/ /pubmed/34514502 http://dx.doi.org/10.1242/dmm.049077 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Resource Article
Rahman, Anum
DeYoung, Taylor
Cahill, Lindsay S.
Yee, Yohan
Debebe, Sarah K.
Botelho, Owen
Seed, Mike
Chaturvedi, Rajiv R.
Sled, John G.
A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow
title A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow
title_full A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow
title_fullStr A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow
title_full_unstemmed A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow
title_short A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow
title_sort mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow
topic Resource Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592017/
https://www.ncbi.nlm.nih.gov/pubmed/34514502
http://dx.doi.org/10.1242/dmm.049077
work_keys_str_mv AT rahmananum amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT deyoungtaylor amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT cahilllindsays amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT yeeyohan amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT debebesarahk amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT botelhoowen amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT seedmike amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT chaturvedirajivr amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT sledjohng amousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT rahmananum mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT deyoungtaylor mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT cahilllindsays mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT yeeyohan mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT debebesarahk mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT botelhoowen mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT seedmike mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT chaturvedirajivr mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow
AT sledjohng mousemodelofhypoplasticleftheartsyndromedemonstratinglefthearthypoplasiaandretrogradeaorticarchflow